Check out our most popular compounded medications! Get Started
The Exemestane 5 mg/ml Gastric Tube Liquid is a specially compounded medication intended for administration through a gastric tube. This formulation is designed to provide a precise dosage of exemestane, an aromatase inhibitor, to patients who are unable to swallow oral medications. It is commonly utilized in hospital settings or for home care patients with swallowing difficulties. The liquid formulation ensures that the medication is delivered safely and effectively to the site of action.
Exemestane is primarily used in the treatment of estrogen-receptor positive breast cancer in postmenopausal women. It functions by decreasing the amount of estrogen produced by the body, which can slow or reverse the growth of certain types of breast tumors that require estrogen to grow. This gastric tube liquid formulation is particularly beneficial for patients who are undergoing cancer treatment and have compromised swallowing ability or gastrointestinal issues that preclude the use of solid dosage forms.
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Exemestane 5 mg/ml Gastric Tube Liquid is a specialized formulation designed to facilitate the administration of exemestane, a steroidal aromatase inhibitor, through a gastric tube. This delivery method is particularly beneficial for patients who are unable to take oral medications due to swallowing difficulties or other medical conditions that impair oral intake. The liquid formulation ensures that the medication is delivered in a precise and controlled manner, which is crucial for maintaining the appropriate therapeutic levels of the drug in the body.
Exemestane is primarily used in the treatment of hormone-receptor-positive breast cancer in postmenopausal women. It functions by inhibiting the aromatase enzyme, which is responsible for the conversion of androgens to estrogens in peripheral tissues. By decreasing estrogen levels, exemestane helps to slow down or reverse the growth of certain types of breast tumors that require estrogen to grow. This medication is often prescribed as part of adjuvant therapy following surgery or radiation to reduce the risk of cancer recurrence, as well as for the management of advanced-stage or metastatic breast cancer.
The preparation of Exemestane 5 mg/ml Gastric Tube Liquid requires meticulous attention to ensure stability, sterility, and proper concentration of the active ingredient. As compounding pharmacists at Bayview Pharmacy, we adhere to stringent compounding protocols to create a high-quality product that meets the specific needs of our patients. We also provide comprehensive counseling to both patients and prescribers on the proper use and handling of this medication, including storage, administration techniques, and potential side effects.
It is important for prescribers to consider the individual patient's medical history, concurrent medications, and overall treatment plan when prescribing Exemestane 5 mg/ml Gastric Tube Liquid. Monitoring for therapeutic efficacy and adverse reactions is essential to ensure optimal patient outcomes. For any questions or additional information regarding this formulation, please do not hesitate to reach out to us at Bayview Pharmacy. Our team is dedicated to providing support and guidance to ensure the safe and appropriate use of this medication.
Exemestane is an aromatase inhibitor used primarily in the treatment of estrogen-receptor positive breast cancer in postmenopausal women. It works by decreasing the amount of estrogen the body makes, which can slow or reverse the growth of some breast cancers. When formulating exemestane as a 5 mg/ml gastric tube liquid, it is crucial to consider potential drug interactions that may affect the efficacy and safety of the medication.
Exemestane should be used with caution when co-administered with drugs that are strong inducers or inhibitors of CYP3A4, an enzyme responsible for the metabolism of exemestane. Strong CYP3A4 inducers, such as rifampicin, phenytoin, carbamazepine, and St. John's Wort, may decrease plasma concentrations of exemestane, potentially reducing its therapeutic effect. Conversely, strong CYP3A4 inhibitors like ketoconazole, itraconazole, and ritonavir may increase plasma concentrations of exemestane, leading to an increased risk of side effects.
Additionally, exemestane should be used with caution when administered with drugs that have a narrow therapeutic index and are metabolized by CYP3A4. Adjustments in the dosage of these drugs may be necessary when they are used concurrently with exemestane.
Estrogen-containing therapies, including hormonal contraceptives and hormone replacement therapy, should not be used with exemestane, as they may counteract its pharmacological action. Patients should be advised to avoid these medications unless deemed necessary and discussed with their healthcare provider.
Exemestane is also known to decrease bone mineral density, which can increase the risk of osteoporosis and fractures. Medications that also affect bone density, such as glucocorticoids or other aromatase inhibitors, should be co-administered with caution, and bone health should be monitored regularly.
It is important to note that the absorption of exemestane may be affected by the pH of the stomach. Medications that alter gastric pH, such as proton pump inhibitors (PPIs) and H2-receptor antagonists, could potentially affect the absorption of exemestane when administered via a gastric tube. Monitoring the patient's response to exemestane and adjusting the dose as necessary is recommended when these medications are used concomitantly.
Patients should be advised to inform their healthcare providers of all medications, supplements, and herbal products they are taking to ensure that potential interactions with exemestane can be assessed and managed appropriately. If you have any questions or require further information regarding drug interactions with exemestane 5 mg/ml gastric tube liquid, please reach out to us at Bayview Pharmacy for assistance.
The Exemestane 5 mg/ml Gastric Tube Liquid is a specialized pharmaceutical formulation designed to facilitate the administration of the active ingredient, exemestane, through a gastric tube. Exemestane is a type of medication known as an aromatase inhibitor, which is primarily used in the treatment of certain forms of breast cancer. It works by inhibiting the enzyme aromatase, which is responsible for the conversion of androgens (hormones produced by the adrenal glands) into estrogens. In postmenopausal women, this conversion is the principal source of estrogen, and by blocking this process, exemestane reduces estrogen levels in the body. This reduction is beneficial in hormone receptor-positive breast cancer, as these cancer cells require estrogen to grow and multiply. By depriving them of estrogen, exemestane helps to slow or stop the growth of the cancer cells.
The liquid formulation is specifically designed for patients who are unable to swallow pills or tablets, such as those with dysphagia or those who are using a gastric tube for other medical reasons. The use of a gastric tube allows for direct delivery of the medication to the stomach, bypassing the need for swallowing and ensuring that the correct dose is received by the patient.
For prescribers, it is important to note that the Exemestane 5 mg/ml Gastric Tube Liquid should be used with caution in patients with liver or kidney impairment, as these conditions can affect the metabolism and excretion of the drug. Additionally, the liquid formulation may contain excipients that need to be considered in patients with specific allergies or sensitivities. As with any medication, monitoring for side effects and interactions with other drugs is essential.
It is also not indicated for use in pregnant or breastfeeding women due to the potential for harm to the developing fetus or nursing infant.
If you have any questions or require further information about the Exemestane 5 mg/ml Gastric Tube Liquid, please do not hesitate to reach out to us at Bayview Pharmacy. Our team of compounding pharmacists is here to provide support and guidance to ensure the safe and appropriate use of this medication.
Exemestane 5 mg/ml Gastric Tube Liquid is used to treat certain types of breast cancer in postmenopausal women. The liquid formulation is intended for patients who are unable to swallow pills or tablets, such as those who have difficulty swallowing or who are on feeding tubes.
This medication is administered directly via a gastric tube. This allows for the precise and controlled delivery of Exemestane into a patient's stomach, bypassing the need for oral ingestion.
While Exemestane Gastric Tube Liquid is safe for many patients, it is not suitable for everyone. Patients with certain medical conditions or those who are taking specific medications should consult with their healthcare provider to ensure that it's safe for use. Allergies to the active ingredient or the formulation must also be considered.
The liquid form ensures that the medication can be administered to patients with swallowing difficulties or those who rely on a gastric tube for nutrition and medications. It also allows for precise dosing, which is particularly important for drugs like Exemestane where maintaining the correct dose is crucial for treatment effectiveness.
While it is specifically designed for patients with swallowing difficulties or those who have a gastric tube, it may be used for patients who can swallow tablets if deemed appropriate by their healthcare provider.
The liquid should be stored in a cool, dry place away from light and moisture, and out of reach of children and pets. The storage temperature recommendations should be followed according to the product label or as advised by a pharmacist.
As with any medication, there may be potential side effects. Common side effects could include hot flashes, fatigue, and nausea. It's important to report any severe or persistent side effects to a healthcare provider immediately.
The dosage is prescribed by a healthcare provider based on the patient’s medical condition and response to treatment. Any adjustments to the dosage should be done under professional supervision.
If a dose is missed, it should be administered as soon as you remember. However, if it is near the time for the next dose, skip the missed dose and resume the usual dosing schedule. Do not double the dose to catch up. It is important to follow a regular dosing schedule and consult with a healthcare provider if there are any uncertainties.
Generally, no special preparation is required other than ensuring that the gastric tube is clear and properly positioned. However, it's important to shake the bottle well before each dose and to administer the medication according to the instructions provided by the healthcare provider or pharmacist.
Yes, Exemestane can interact with other medications. It is essential to inform your healthcare provider about all the medications you are taking, including prescription, over-the-counter, and herbal supplements. This will help to avoid potential drug interactions.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
